GW Pharmaceuticals PLC (GWPH)

99.62
0.87 0.88
NASDAQ : Health Care
Prev Close 98.75
Open 98.45
Day Low/High 98.45 / 100.63
52 Wk Low/High 35.83 / 120.99
Volume 224.48K
Avg Volume 299.00K
Exchange NASDAQ
Shares Outstanding 25.33M
Market Cap 2.53B
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Snap-On, Teekay Shipping, FLIR Systems, GW Pharmaceuticals: 'Mad Money' Lightning Round

Snap-On, Teekay Shipping, FLIR Systems, GW Pharmaceuticals: 'Mad Money' Lightning Round

Jim Cramer is bearish on Snap-On, Teekay Shipping, FLIR Systems, and GW Pharmaceuticals.

Time to Raise Some Cash: Cramer's 'Mad Money' Recap (Tuesday 8/1/17)

Time to Raise Some Cash: Cramer's 'Mad Money' Recap (Tuesday 8/1/17)

Jim Cramer says last week's selloff played out just like he predicted, and you haven't missed the sale.

10 Stocks to Give as Gifts

10 Stocks to Give as Gifts

Stocks can be a good gifts for individuals since they can be instrumental in wealth creation and demonstrate the power of compounding.

The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next

The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next

Here are the activist investor's next potential targets.

Launch of Cannabis ETF May Not Be Best Option for Investors

Launch of Cannabis ETF May Not Be Best Option for Investors

Although a cannabis ETF launched in April, investors are still likely to find more value in buying individual stocks in the sector, according to traders.

Alibaba, LAM Research, Yahoo, Applied Materials, Momo: 'Mad Money' Lightning Round

Alibaba, LAM Research, Yahoo, Applied Materials, Momo: 'Mad Money' Lightning Round

Jim Cramer takes on LAM Research, Yahoo, Alibaba, Applied Materials, and Momo in the Lightning Round.

More Companies Making New Highs: Cramer's 'Mad Money' Recap (Wednesday 5/31/17)

More Companies Making New Highs: Cramer's 'Mad Money' Recap (Wednesday 5/31/17)

This is not just a tech-led rally, says Jim Cramer. Keep an eye on stocks like Boeing, CSX, 3M and Carnival.

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Aerie Pharmaceuticals, BioCryst Pharmaceuticals and GW Pharmaceuticals were among the biotech movers in premarket trading on Thursday.

Analysts' Actions -- Chemours, Incyte, Visteon, Toyota and More

Analysts' Actions -- Chemours, Incyte, Visteon, Toyota and More

Here are Friday's top research calls, including upgrades for Chemours, Incyte and Toyota, and new coverage of Visteon.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: SOHO, TM, VEC, WWW Downgrades: BID, FF, GWPH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Bull Market Reaching Mature Stage, Dow Could Dip to 19,000

Bull Market Reaching Mature Stage, Dow Could Dip to 19,000

The rallies in the stock market could be indicators of irrational exuberance and are not sustainable because of anemic growth, low unemployment and high valuations in equities.

Analysts Actions -- Costco, McDonald's, GW Pharma, Kinder Morgan and More

Analysts Actions -- Costco, McDonald's, GW Pharma, Kinder Morgan and More

Here are Friday's top research calls, including an upgrade for Costco and new coverage of McDonald's, GW Pharma and Kinder Morgan.

Happy 420! A Roundup of Investing Advice in the Green Gold Rush

Happy 420! A Roundup of Investing Advice in the Green Gold Rush

As more states legalize, your portfolio could smoke the competition.

GW Pharmaceuticals And Its U.S. Subsidiary Greenwich Biosciences Highlight New Epidiolex® (cannabidiol) Data Released By The American Academy Of Neurology

More Detailed Poster Presentation Scheduled for April 25, 2017 at AAN Annual Meeting

GW Pharmaceuticals And Its U.S. Subsidiary Greenwich Biosciences To Present Data On Epidiolex® (cannabidiol) At The 2017 American Academy Of Neurology Annual Meeting

- New Phase 3 Data in Lennox-Gastaut Syndrome Selected for Inclusion in the Emerging Science Program -

Collect Smokin' Hot Profits From This Marijuana Biotech

Collect Smokin' Hot Profits From This Marijuana Biotech

This innovative biotech offers investors an intriguing play on the medical marijuana business.

Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs

Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs

In the first quarter of the year we've seen some high-profile IPOs. But they're not all created equal. Here's what investors should keep an eye out for ... and avoid.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMRK, AXTA, DFT, GWPH, LBRDK, LBTYA, RPM Downgrades: CIEN, CRNT, IMO, SUNW, TG, TRIB, USCR Initiations: FBIO Read on to get TheStreet Quant Ratings' detailed report:

Bring On The Rate Hike!: Cramer's 'Mad Money' Recap (Friday 3/10/17)

Bring On The Rate Hike!: Cramer's 'Mad Money' Recap (Friday 3/10/17)

This economy is finally strong enough that a rate hike is natural and necessary, says Jim Cramer.